Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on November 9, 2020. The filing serves to announce the Company's financial results for the period ended September 30, 2020, and provides an update on recent corporate events. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results are contained within the attached Exhibits (99.1 and 99.2) rather than the body of the 8-K itself.
Material Changes
The filing does not detail specific material changes versus prior periods within the text provided. It references the issuance of a press release and stockholder letter containing the comparative financial data and updates on corporate events.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished under Item 2.02, including the exhibits, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. Furthermore, the Company explicitly states it does not assume any obligation to update the information or exhibits in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net loss, and cash position figures for the period ended September 30, 2020.
- Examine Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and strategic updates.
- Verify the Company's liquidity status and debt obligations as detailed in the attached exhibits, as these are not listed in the 8-K summary text.
- Note that the Company has disclaimed any obligation to update the forward-looking information or financial data provided in this filing.